Glauconix is contract research organization (CRO) serving the biopharma industry by providing an innovative service using a patented platform to accelerate glaucoma drug development. The team is comprised of key opinion leaders in the ophthalmic industry. This year-old company has generated over $600K in customer revenue. Glauconix is raising capital to grow the company and meet the demands of the world’s largest pharmaceutical companies.